Trial Profile
Pharmacokinetic study of Cefepime and tazobactam in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 01 Oct 2016
Price :
$35
*
At a glance
- Drugs Cefepime/tazobactam (Primary)
- Indications Gram-negative infections; Intra-abdominal infections; Nosocomial pneumonia; Urinary tract infections
- Focus Pharmacokinetics
- 01 Oct 2016 New trial record